These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1916100)

  • 1. State-of-the-art biomolecular core facilities: a comprehensive survey.
    Niece RL; Beach CM; Cook RF; Hathaway GM; Williams KR
    FASEB J; 1991 Oct; 5(13):2756-60. PubMed ID: 1916100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The size, operation, and technical capabilities of protein and nucleic acid core facilities.
    Williams KR; Niece RL; Atherton D; Fowler AV; Kutny R; Smith AJ
    FASEB J; 1988 Dec; 2(15):3124-30. PubMed ID: 3192042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotechnology core facilities: trends and update.
    Ivanetich KM; Niece RL; Rohde M; Fowler E; Hayes TK
    FASEB J; 1993 Sep; 7(12):1109-14. PubMed ID: 8375609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotechnology core laboratories: An overview.
    McMillen DA; Bibbs L; Denslow N; Ivanetich KM; Naeve C; Niece RL; Tindall S
    J Biomol Tech; 2000 Mar; 11(1):1-11. PubMed ID: 19499032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of nucleic acid services in core laboratories.
    Pon RT; Buck GA; Niece RL; Robertson M; Smith AJ; Spicer E
    Biotechniques; 1994 Sep; 17(3):526-34. PubMed ID: 7818907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fall and rise of cost sharing in Kenya: the impact of phased implementation.
    Collins D; Quick JD; Musau SN; Kraushaar K; Hussein IM
    Health Policy Plan; 1996 Mar; 11(1):52-63. PubMed ID: 10155878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. User fees and maternity services in Ethiopia.
    Pearson L; Gandhi M; Admasu K; Keyes EB
    Int J Gynaecol Obstet; 2011 Dec; 115(3):310-5. PubMed ID: 21982855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New sequencers to take on the genome.
    Roberts L
    Science; 1987 Oct; 238(4825):271-3. PubMed ID: 3659916
    [No Abstract]   [Full Text] [Related]  

  • 9. Survey of current trends in DNA synthesis core facilities.
    Hager KM; Fox JW; Gunthorpe M; Lilley KS; Yeung A
    J Biomol Tech; 1999 Dec; 10(4):187-93. PubMed ID: 19499025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa.
    Cassim N; Coetzee LM; Schnippel K; Glencross DK
    PLoS One; 2014; 9(12):e115420. PubMed ID: 25517412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health for some? The effects of user fees in the Volta Region of Ghana.
    Nyonator F; Kutzin J
    Health Policy Plan; 1999 Dec; 14(4):329-41. PubMed ID: 10787649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracking implementation and (un)intended consequences: a process evaluation of an innovative peripheral health facility financing mechanism in Kenya.
    Waweru E; Goodman C; Kedenge S; Tsofa B; Molyneux S
    Health Policy Plan; 2016 Mar; 31(2):137-47. PubMed ID: 25920355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. User charges in government health facilities in Kenya: effect on attendance and revenue.
    Mwabu G; Mwanzia J; Liambila W
    Health Policy Plan; 1995 Jun; 10(2):164-70. PubMed ID: 10143454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the introduction of user fees at a district hospital in Cambodia.
    Jacobs B; Price N
    Health Policy Plan; 2004 Sep; 19(5):310-21. PubMed ID: 15310666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges for proteomics core facilities.
    Lilley KS; Deery MJ; Gatto L
    Proteomics; 2011 Mar; 11(6):1017-25. PubMed ID: 21360676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of biomolecular resource facilities survey: service laboratory funding.
    Ogorzalek Loo R; Nicolet CM; Niece RL; Young M; Simpson JT
    J Biomol Tech; 2009 Jul; 20(3):180-5. PubMed ID: 19568457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why small matters.
    Nat Biotechnol; 2003 Oct; 21(10):1113. PubMed ID: 14520377
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of alternative cost recovery schemes on access and equity in Niger.
    Diop F; Yazbeck A; Bitrán R
    Health Policy Plan; 1995 Sep; 10(3):223-40. PubMed ID: 10151841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who benefits from removing user fees for facility-based delivery services? Evidence on socioeconomic differences from Ghana, Senegal and Sierra Leone.
    McKinnon B; Harper S; Kaufman JS
    Soc Sci Med; 2015 Jun; 135():117-23. PubMed ID: 25965892
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.